De Brauw advised Assicurazioni Generali SpA, a leading global integrated insurer and asset manager, on the combination of its asset management operations with Natixis Investment Managers, part of Groupe BPCE, a leading French banking group. The deal is valued at EUR 9.5 billion.

De Brauw advises Pontegadea, the investment vehicle of Inditex founder Amancio Ortega and focused on a wide range of sectors as real estate, energy, infrastructure or retail, on the acquisition of a 20% stake in Q-Park from its existing majority shareholder KKR. Q-Park is a leading European parking infrastructure owner and operator, with a large and diversified portfolio of approximately 4,400 owned, leased and managed parking facilities in The Netherlands, Germany, France, Belgium, United Kingdom, Ireland and Denmark. Q-Park focuses on off-street, strategic prime locations and works together with municipalities and landlords to implement sustainable urban mobility plans, leveraging its industry-leading digital capabilities, strategic growth framework and its sizeable and rapidly expanding EV charging offering.

On 18 December 2024, FrieslandCampina and Milcobel announced their intention to merge. De Brauw assists FrieslandCampina on this important step in the joint future of FrieslandCampina and Milcobel. By combining their forces, a leading dairy cooperative and dairy company will be created. The merger is intended to provide a strong foundation for a future-oriented organisation that has dairy front and centre for member dairy farmers, employees, consumers, and customers.

De Brauw advised Royal BAM Group N.V. on the divestment of its 50% share in Invesis to joint venture partner PGGM Infrastructure Fund. The parties have reached conditional agreement on this divestment. The closing of the transaction, which is subject to obtaining relevant authority clearance and completion of the works council consultation process, is expected to take place early 2025.

De Brauw assisted Paulig in its acquisition of Conimex from Unilever.

De Brauw advised the underwriters on the upsized USD 479 million public offering of shares and pre-funded warrants by NASDAQ listed NewAmsterdam Pharma Company N.V.

De Brauw advised Pon on the sale of its remaining sales, rental and service activities for Caterpillar construction equipment in the Netherlands and Norway to the German Zeppelin Group. In 2019, Pon already sold its Caterpillar activities in Denmark and Sweden to Zeppelin. Pon will continue to focus on mobility through its automotive and bikes activities.

De Brauw advised APG Asset Management N.V. on the structuring and fundraising of APG Infrastructure Asset Owner Fund III C.V.

De Brauw advised investment firm JAB on its acquisition of Mondelez’s 86 million shares in (Euronext Amsterdam listed) JDE Peet’s for EUR 25.10 per share, representing a total purchase price of approximately EUR 2.2 billion. Additionally, JAB distributed shares of JDE Peet’s to more than 70 outside investors in JAB Consumer Partners, significantly increasing the free float of JDE Peet’s. The distribution reflects the final distribution of JDE Peet’s shares to JCP investors. As a result of these transactions, JAB’s stake in JDE Peet’s increased to 68%.

De Brauw advised CTP N.V. on its EUR 300 million equity raise through an accelerated bookbuild offering.

QIAGEN N.V. has launched an issuance of USD 500 million senior unsecured net share settled convertible bonds. This type of bond differs from "regular" convertible bonds in that they may only partly - for the amount "in the money" under the embedded warrant - be converted into ordinary shares of the company. In the event of an exercise of their conversion right, holders of the convertible bonds receive a cash amount equivalent to the par value of the convertible bonds, plus a number of shares such that the sum of the cash amount and value of shares delivered is equivalent to the value of the shares underlying the convertible bonds. The 7-year convertible bonds with a denomination of USD 200,000 each carry a conversion price that represents a premium of 44% above the reference price of the shares.

De Brauw advised IMCD N.V. on its EUR 300 million capital raise through an accelerated bookbuilding offering (ABB) of new ordinary shares. The new shares to be issued represent circa 3.5% of IMCD's issued share capital. The capital raise will provide IMCD increased financial flexibility and further strengthen its balance sheet.